BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 20, 2007
View Archived Issues
PTP-1B inhibitors claimed in recent patent by Metabasis
Read More
Several series of protein kinase inhibitors claimed for the treatment of cancer
Read More
Eisai announces first quarter results
Read More
Curcumin reverses amyloid pathology in mouse model of Alzheimer's disease
Read More
Cholesterol biosynthesis inhibitor reduces amyloid-beta in vitro
Read More
Denufosol improves lung function in phase II cystic fibrosis study
Read More
First half 2007 results reported by sanofi-aventis
Read More
Urigen begins phase II study of URG-101 for PBS
Read More
Allos begins enrollment for phase I study of PDX with vitamin B12 and folic acid
Read More
CombinatoRx begins phase IIa study of CRx-401 for type 2 diabetes
Read More
Millennium begins phase II trial of Velcade for MM
Read More
Positive results for Neuraxon's phase I trial of NXN-188 for migraine
Read More
Accentia reports interim analysis of phase III trial of SinuNase for CS
Read More
GSK begins phase I trial of GSK-923295 for solid tumors
Read More
VGX begins IND-enabling preclinical toxicology studies of three product candidates
Read More
EKR acquires marketing rights to Pacira's DepoDur for postoperative pain
Read More
New recombinant neuregulin-1 ameliorates cardiac output in chronic heart failure
Read More
Noven acquisition of JDS Pharmaceuticals completed
Read More
Parion and Gilead to codevelop ENaC inhibitors for pulmonary diseases
Read More
Vion enrolls 85 elderly patients in pivotal phase II trial of Cloretazine for AML
Read More
European Commission grants Chelsea Therapeutics' droxidopa two orphan drug titles
Read More
EMEA recommends orphan drug status for Progen's PI-88 as it enters phase III trial
Read More
The MMRC and Proteolix start carfilzomib phase II clinical trial in multiple myeloma
Read More
Oncoscience completes enrollment in phase III brain cancer trial of nimotuzumab
Read More
Hedgehog signaling activators discovered with potential in neurodegenerative disorders
Read More
Novel, potent hydroxyhydantoin MMP inhibitors presented at ACS meeting
Read More
FDA approves Novartis' once-yearly Reclast for postmenopausal osteoporosis
Read More